Inhibikase Invest Information

Companies
Inhibikase Therapeutics Reports Preliminary FDA Meeting Outcomes for IkT-001Pro Feb 8, 2024
Earnings
Inhibikase Therapeutics Announces Q3 Financial Results and Activities Update Nov 15, 2023